Citius Oncology
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,493 | $1,667 | $3,944 | $0 |
Gross Profit | -718 | 1,338 | 3,154 | |
EBITDA | -6,996 | -26,807 | -4,650 | -4,675 |
EBIT | -8,716 | -5,223 | ||
Net Income | -8,923 | -26,609 | -5,534 | -4,996 |
Net Change In Cash | 1,493 | 1,667 | 3,944 | 0 |
Free Cash Flow | -2,848 | -3,967 | -7,354 | -5,534 |
Cash | 16,563 | 2,632 | 7,295 | 3,924 |
Basic Shares | 107,890 | 100,027 | 87,462 | 80,944 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -23,486 | -20,572 | -12,121 | -4,856 |
EBIT | -20,572 | -12,121 | -4,856 | |
Net Income | -24,761 | -21,148 | -12,697 | -10,865 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,492 | 126 | -601 | -47 |
Cash | 3,924 | 26 | 289 | |
Basic Shares | 73,267 | 71,552 | 89,479 | 90,160 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.08 |
2026-03-31 | -$0.27 |
2025-12-31 | -$0.06 |
2025-09-30 | -$0.06 |